417 related articles for article (PubMed ID: 11402322)
1. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
[TBL] [Abstract][Full Text] [Related]
2. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3.
Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J
Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517
[TBL] [Abstract][Full Text] [Related]
3. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
Lassus H; Salovaara R; Aaltonen LA; Butzow R
Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
[TBL] [Abstract][Full Text] [Related]
4. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma.
Takebayashi S; Ogawa T; Jung KY; Muallem A; Mineta H; Fisher SG; Grenman R; Carey TE
Cancer Res; 2000 Jul; 60(13):3397-403. PubMed ID: 10910046
[TBL] [Abstract][Full Text] [Related]
5. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
6. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
[TBL] [Abstract][Full Text] [Related]
7. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer.
Takei K; Kohno T; Hamada K; Takita J; Noguchi M; Matsuno Y; Hirohashi S; Uezato H; Yokota J
Cancer Res; 1998 Aug; 58(16):3700-5. PubMed ID: 9721881
[TBL] [Abstract][Full Text] [Related]
8. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
9. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes.
Kagan J; Stein J; Babaian RJ; Joe YS; Pisters LL; Glassman AB; von Eschenbach AC; Troncoso P
Oncogene; 1995 Nov; 11(10):2121-6. PubMed ID: 7478532
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of Smad4 in gastric carcinomas.
Powell SM; Harper JC; Hamilton SR; Robinson CR; Cummings OW
Cancer Res; 1997 Oct; 57(19):4221-4. PubMed ID: 9331080
[TBL] [Abstract][Full Text] [Related]
11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
12. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
[TBL] [Abstract][Full Text] [Related]
13. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
14. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
[TBL] [Abstract][Full Text] [Related]
17. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas.
MacGrogan D; Pegram M; Slamon D; Bookstein R
Oncogene; 1997 Aug; 15(9):1111-4. PubMed ID: 9285566
[TBL] [Abstract][Full Text] [Related]
18. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer.
Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL
Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782
[TBL] [Abstract][Full Text] [Related]
19. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
[TBL] [Abstract][Full Text] [Related]
20. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
